Drug utilization studies: Their importance for post-marketing surveillance

被引：0
|
作者：
Castro, Lia C. [1 ]
机构：
[1] SOBRAVIME, Sao Paulo, Brazil
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2007年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
200
引用
收藏
页码：S95 / S96
页数：2
相关论文
共 50 条
  • [21] A PRESCRIPTION FOR POST-MARKETING SURVEILLANCE
    ROUTMAN, KD
    DRUG & COSMETIC INDUSTRY, 1980, 126 (06): : 60 - 64
  • [22] Post-marketing Surveillance Systems for Psychoactive Prescription Drug Abuse
    Nordmann, Sandra
    Frauger, Elisabeth
    Pauly, Vanessa
    Rouby, Frank
    Mallaret, Michel
    Micallef, Joelle
    Thirion, Xavier
    THERAPIE, 2011, 66 (03): : 263 - 272
  • [23] Correspondents in post-marketing surveillance, drug dependence surveillance and toxicovigilance: definition and roles
    Rioufol, C
    Vial, T
    Pulce, C
    Descotes, J
    THERAPIE, 2002, 57 (02): : 201 - 204
  • [24] Efficacy and safety of nateglinide in post-marketing surveillance studies in Japan
    Damholt, BB
    Golor, G
    Wierich, W
    Pedersen, PC
    Ekblom, M
    Zdravkovic, M
    DIABETES, 2005, 54 : A114 - A114
  • [25] POST-MARKETING SURVEILLANCE OF NEW MEDICINES
    SMITHELLS, RW
    BRITISH MEDICAL JOURNAL, 1977, 2 (6096): : 1218 - 1218
  • [26] Optimization of the post-marketing surveillance procedure
    Kalle, Parminder
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (02) : 125 - 127
  • [27] Post-marketing surveillance of novel foods
    Warner, JO
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2002, 13 (06) : 385 - 385
  • [28] Post-marketing device safety surveillance
    Vidi, Venkatesan D.
    Matheny, Michael E.
    Resnic, Frederic S.
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (03) : 307 - 308
  • [29] POST-MARKETING SURVEILLANCE OF MEDICINES IN THE UK
    GRIFFIN, JP
    BAKER, R
    PHARMACY INTERNATIONAL, 1981, 2 (09): : 203 - 209
  • [30] Sodium Oxybate Post-Marketing Surveillance
    Feldman, Neil T.
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2011, 7 (04): : 417 - 417
12345